Online, On-Demand Recording
Class description
Occupational and environmental health exposures cause thousands of illnesses and injuries each year. This lecture series addresses the evaluation, treatment, and prevention of disease and injuries related to environmental and occupational exposures encountered by physicians and their colleagues in local, regional, and international settings.
On-Demand, Online Recording of Live Lecture from March 20, 2023
OEM Grand Rounds - Traumatic Brain Injuries
Presenter: Jennifer M Zumsteg, MD, Inpatient - Rehabilitation Medicine (PM&R), Consultant, UW Medicine, Valley Medical Center
View the OEM Grand Rounds Lecture Series flyer.
On-demand online recording available NOW through 4/20/25.
LECTURE OVERVIEW
Dr. Zumsteg reviews evaluation and management of traumatic brain injury (TBI) with a focus on mild TBI/concussion. Topics include screening and management of common symptoms/sequalae after TBI, examples of screening and physical examination tools for healthcare providers, and relevant functional prognosis. Dr. Zumsteg reviews frameworks for return to physical work and cognitive work/learning activities for workers injured both on and off the job, and suggested regional and national resources to support care and recovery, especially for workers with moderate-severe TBI and those with prolonged symptoms.
PRESENTER BIO
Dr. Zumsteg received her medical degree from the University of Chicago, Pritzker School of Medicine and completed PM&R residency at University of Washington. She is board-certified in physical medicine and rehabilitation and brain injury medicine. In her commitments to professional service and advocacy she is active as a volunteer with organizations including the American Board of PM&R and the American Academy of PM&R. She is an investigator on the UW Traumatic Brain Injury Model System and past TBI fellowship director.
Jennifer M. Zumsteg, MD, has an interest in acquired brain injury and neurorehabilitation care across the care continuum. She strives to improve community health and well-being through treatments that optimize function to meet individualized patient goals, providing evidence-based physical medicine and rehab (PM&R) medical consultation, and contributing to safe care and innovation in high-functioning health care teams.
ACCREDITATION
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and the Northwest Center for Occupational Health and Sciences, University of Washington Department of Environmental and Occupational Health Sciences. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: Credit Designation Statement – Enduring Materials
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until {April 20, 2025}. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.25 nursing contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Jennifer M Zumsteg’s discussion of Traumatic Brain Injury. She will be discussing current treatments for TBI, none which are FDA approved medications for symptom management. Therefore, the information that the treatments are “off-label.”
If CEU only, Joint Provider: The Centers for Disease Control and Prevention and Northwest Center for Occupational Health and Safety are jointly providing the CEUs for this activity.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.